Evidence map›Paper›PMID 34128409›Full record

ArticleCartilage2021

Cartilage Biomarkers Coll2-1 and Coll2-1NO2 Are Associated with Knee OA MRI Features and Are Helpful in Identifying Patients at Risk of Disease Worsening.

Anne-Christine Hick, Michel Malaise, Damien Loeuille, Thierry Conrozier, Yves Maugars, Franz Pelousse, Cédric Tits, Yves Henrotin

Abstract read
In one paragraph

Article in Cartilage, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anne-Christine HickARTIALIS SA, CHU Sart-Tilman, Liège, Belgium.ORCID 0000-0001-5931-052X
Michel MalaiseDepartment of Rheumatology, CHU Sart Tilman, University of Liège, Liège, Belgium.
Damien LoeuilleDepartment of Rheumatology, University Hospital of Nancy, Vandœuvre-lès-Nancy, France.
Thierry ConrozierDepartment of Rheumatology, Hôpital Nord Franche-Comté, Belfort, France.
Yves MaugarsService de rhumatologie, Hôtel-Dieu, CHU de Nantes, France.
Franz PelousseSODIRAY, Solution Diagnostique Radiologique, Liège, Belgium.
Cédric TitsDNAlytics, Louvain-la-Neuve, Belgium.
Yves HenrotinARTIALIS SA, CHU Sart-Tilman, Liège, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the cross-sectional association between serum levels of Coll2-1 and Coll2-1NO2, two cartilage degradation biomarkers; the burden of magnetic resonance imaging (MRI) features and clinical outcomes; and to evaluate the predictive value of these biomarkers on progression.

designA total of 121 subjects with knee osteoarthritis (OA) were followed during 1 year with pain, function, and MRI assessment (PRODIGE study). Type II collagen-specific biomarker Coll2-1 and its nitrated form Coll2-1NO2 were directly measured in serum using immunoassays at baseline and after 3-, 6-, and 12-month follow-up.

resultsSerum Coll2-1 and Coll2-1NO2 were correlated with several baseline knee features quantified with Whole-Organ Magnetic Resonance Imaging Score (WORMS). Coll2-1 was significantly correlated with periarticular cysts/bursitis (ρ = 0.29,

conclusionSerum cartilage biomarkers Coll2-1 and Coll2-1NO2 are associated with several knee OA features quantified with WORMS. Our study also shows that the baseline value of Coll2-1NO2 is positively associated with pain worsening.

Indexed as

AgedAged, 80 and overBiomarkersCartilage, ArticularCollagen Type IICross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedOsteoarthritis, KneePainPeptide FragmentsRisk AssessmentBiomarkersCollagen Type IIcollagen type II (108-116)collagen type II (108-116), (NO2)Tyr(111)-Peptide Fragmentsarticular cartilagebiomarkersclinical trialdiagnosisdiagnosticsgeneralOA progressionosteoarthritistissue

Identifiers

PMID34128409
PMCPMC8808823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.